Breaking

Optimizing GLP-1 Drug Efficiency and Affordability in Virtual Care: JPM Week HighlightsThe J.P. Morgan Health Care conference in San Francisco this week was abuzz with discussions surrounding the future of GLP-1 medications, their expanding...

DEA Introduces New Telehealth Rules for Controlled SubstancesThe Drug Enforcement Administration (DEA) has finally unveiled a long-awaited announcement regarding the prescription of controlled substances through telemedicine. This groundbreaking move comes after a 16-year delay...

Alignment Healthcare Stands Strong Amidst Industry TurmoilIn the midst of the chaos at the J.P. Morgan Healthcare Conference, one company stands out - Alignment Healthcare. Amidst the absence of major health insurers at the...

Highlights from J.P. Morgan Healthcare Conference Day 2The J.P. Morgan Healthcare Conference on Day 2 saw a flurry of activity, with key industry figures making headlines and sharing insights that could shape the future...

Federal Court Ruling Benefits Nursing Home Residents with Disabilities: Q&AOver the past three decades, a significant shift in health policy has emerged, focusing on enabling individuals with disabilities to live and receive care in...

Unveiling JPM Day 1: A Comprehensive Overview for InvestorsWelcome to STAT’s exclusive coverage of the much-anticipated “JPM Week” in San Francisco, where the biotech world is abuzz with groundbreaking news, insightful analysis, and juicy...

Healthcare Giants Withdraw from J.P. Morgan ConferenceIn a surprising turn of events, two healthcare giants, Cigna and Centene, have decided to pull out of the highly anticipated J.P. Morgan Healthcare Conference in San Francisco...

Biogen CEO Eyes Biotech Acquisitions: Anticipate Major Deals in 2025SAN FRANCISCO — Chris Viehbacher, the CEO of Biogen, revealed his company's ambitious plans to acquire more biotechs in 2025. In an exclusive interview before...

Challenges in AI Adoption in Biopharma: Exploring the Slow TransformationIn the fast-paced world of biopharmaceuticals, the use of artificial intelligence (AI) is becoming increasingly crucial. With the global demand for cutting-edge treatments...

Patrizia Cavazzoni’s Departure and Its Implications for the FDAPatrizia Cavazzoni, the esteemed leader of the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER), has announced her departure from the agency on...

Breaking News: Aro Biotherapeutics Welcomes Glenn Crater as Chief Medical OfficerIn a significant move within the pharmaceutical industry, Aro Biotherapeutics has recently appointed Glenn Crater as their new Chief Medical Officer. This news comes...

Biden's Medicare Advantage Regulation Boosts Payments to InsurersIn a groundbreaking move that could reshape the landscape of the Medicare Advantage industry, President Biden's Centers for Medicare and Medicaid Services recently unveiled a...